Advances in the Management of Hypertension

References

1. Rowan C. Mahony S. Redahan L. Hypertension in patients receiving dialysis: A review of the current clinical approach. EMJ Nephrol. 2023 11 1 10105805 10.33590/emjnephrol/10105805
   [Google Scholar]
2. Dzau V.J. Balatbat C.A. Future of Hypertension. Hypertension 2019 74 3 450 457 10.1161/HYPERTENSIONAHA.119.13437 31352827
   [Google Scholar]
3. Hunter P.G. Chapman F.A. Dhaun N. Hypertension: Current trends and future perspectives. Br. J. Clin. Pharmacol. 2021 87 10 3721 3736 10.1111/bcp.14825 33733505
   [Google Scholar]
4. Campbell N.R.C. Schutte A.E. Varghese C.V. Ordunez P. Zhang X.H. Khan T. Sharman J.E. Whelton P.K. Parati G. Weber M.A. Orías M. Jaffe M.G. Moran A.E. Liane Plavnik F. Ram V.S. Brainin M. Owolabi M.O. Ramirez A.J. Barbosa E. Bortolotto L.A. Lackland D.T. São Paulo call to action for the prevention and control of high blood pressure: 2020. J. Clin. Hypertens. (Greenwich) 2019 21 12 1744 1752 10.1111/jch.13741 31769155
   [Google Scholar]
5. Whelton P.K. Carey R.M. Aronow W.S. Casey D.E. Jr Collins K.J. Dennison Himmelfarb C. DePalma S.M. Gidding S. Jamerson K.A. Jones D.W. MacLaughlin E.J. Muntner P. Ovbiagele B. Smith S.C. Jr Spencer C.C. Stafford R.S. Taler S.J. Thomas R.J. Williams K.A. Sr Williamson J.D. Wright J.T. Jr 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. J. Am. Coll. Cardiol. 2018 71 19 e127 e248 10.1016/j.jacc.2017.11.006 29146535
   [Google Scholar]
6. Stergiou G.S. Alpert B. Mieke S. Asmar R. Atkins N. Eckert S. Frick G. Friedman B. Graßl T. Ichikawa T. Ioannidis J.P. Lacy P. McManus R. Murray A. Myers M. Palatini P. Parati G. Quinn D. Sarkis J. Shennan A. Usuda T. Wang J. Wu C.O. O’Brien E. A universal standard for the validation of blood pressure measuring devices. J. Hypertens. 2018 36 3 472 478 10.1097/HJH.0000000000001634 29384983
   [Google Scholar]
7. Unger T. Borghi C. Charchar F. Khan N.A. Poulter N.R. Prabhakaran D. Ramirez A. Schlaich M. Stergiou G.S. Tomaszewski M. Wainford R.D. Williams B. Schutte A.E. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension 2020 75 6 1334 1357 10.1161/HYPERTENSIONAHA.120.15026 32370572
   [Google Scholar]
8. Nerenberg K.A. Zarnke K.B. Leung A.A. Dasgupta K. Butalia S. McBrien K. Harris K.C. Nakhla M. Cloutier L. Gelfer M. Lamarre-Cliche M. Milot A. Bolli P. Tremblay G. McLean D. Padwal R.S. Tran K.C. Grover S. Rabkin S.W. Moe G.W. Howlett J.G. Lindsay P. Hill M.D. Sharma M. Field T. Wein T.H. Shoamanesh A. Dresser G.K. Hamet P. Herman R.J. Burgess E. Gryn S.E. Grégoire J.C. Lewanczuk R. Poirier L. Campbell T.S. Feldman R.D. Lavoie K.L. Tsuyuki R.T. Honos G. Prebtani A.P.H. Kline G. Schiffrin E.L. Don-Wauchope A. Tobe S.W. Gilbert R.E. Leiter L.A. Jones C. Woo V. Hegele R.A. Selby P. Pipe A. McFarlane P.A. Oh P. Gupta M. Bacon S.L. Kaczorowski J. Trudeau L. Campbell N.R.C. Hiremath S. Roerecke M. Arcand J. Ruzicka M. Prasad G.V.R. Vallée M. Edwards C. Sivapalan P. Penner S.B. Fournier A. Benoit G. Feber J. Dionne J. Magee L.A. Logan A.G. Côté A.M. Rey E. Firoz T. Kuyper L.M. Gabor J.Y. Townsend R.R. Rabi D.M. Daskalopoulou S.S. Hypertension Canada’s 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children. Can. J. Cardiol. 2018 34 5 506 525 10.1016/j.cjca.2018.02.022 29731013
   [Google Scholar]
9. Stergiou G.S. Kario K. Kollias A. McManus R.J. Ohkubo T. Parati G. Imai Y. Home blood pressure monitoring in the 21st century. J. Clin. Hypertens. (Greenwich) 2018 20 7 1116 1121 10.1111/jch.13284 30003694
   [Google Scholar]
10. Hinderliter A.L. Voora R.A. Viera A.J. Implementing ABPM into Clinical Practice. Curr. Hypertens. Rep. 2018 20 1 5 10.1007/s11906‑018‑0805‑y 29404785
    [Google Scholar]
11. Kitt J. Fox R. Tucker K.L. McManus R.J. New approaches in hypertension management: A review of current and developing technologies and their potential impact on hypertension care. Curr. Hypertens. Rep. 2019 21 6 44 10.1007/s11906‑019‑0949‑4 31025117
    [Google Scholar]
12. Jamaladin H. van de Belt T.H. Luijpers L.C.H. de Graaff F.R. Bredie S.J.H. Roeleveld N. van Gelder M.M.H.J. Mobile apps for blood pressure monitoring: Systematic search in app stores and content analysis. JMIR Mhealth Uhealth 2018 6 11 e187 10.2196/mhealth.9888 30429116
    [Google Scholar]
13. Tucker K.L. Sheppard J.P. Stevens R. Bosworth H.B. Bove A. Bray E.P. Earle K. George J. Godwin M. Green B.B. Hebert P. Hobbs F.D.R. Kantola I. Kerry S.M. Leiva A. Magid D.J. Mant J. Margolis K.L. McKinstry B. McLaughlin M.A. Omboni S. Ogedegbe O. Parati G. Qamar N. Tabaei B.P. Varis J. Verberk W.J. Wakefield B.J. McManus R.J. Self-monitoring of blood pressure in hypertension: A systematic review and individual patient data meta-analysis. PLoS Med. 2017 14 9 e1002389 10.1371/journal.pmed.1002389 28926573
    [Google Scholar]
14. Frieden T.R. Jaffe M.G. Saving 100 million lives by improving global treatment of hypertension and reducing cardiovascular disease risk factors. J. Clin. Hypertens. (Greenwich) 2018 20 2 208 211 10.1111/jch.13195 29370471
    [Google Scholar]
15. Stanaway J.D. Afshin A. Gakidou E. Lim S.S. Abate D. Abate K.H. Abbafati C. Abbasi N. Abbastabar H. Abd-Allah F. Abdela J. Abdelalim A. Abdollahpour I. Abdulkader R.S. Abebe M. Abebe Z. Abera S.F. Abil O.Z. Abraha H.N. Abrham A.R. Abu-Raddad L.J. Abu-Rmeileh N.M.E. Accrombessi M.M.K. Acharya D. Acharya P. Adamu A.A. Adane A.A. Adebayo O.M. Adedoyin R.A. Adekanmbi V. Ademi Z. Adetokunboh O.O. Adib M.G. Admasie A. Adsuar J.C. Afanvi K.A. Afarideh M. Agarwal G. Aggarwal A. Aghayan S.A. Agrawal A. Agrawal S. Ahmadi A. Ahmadi M. Ahmadieh H. Ahmed M.B. Aichour A.N. Aichour I. Aichour M.T.E. Akbari M.E. Akinyemiju T. Akseer N. Al-Aly Z. Al-Eyadhy A. Al-Mekhlafi H.M. Alahdab F. Alam K. Alam S. Alam T. Alashi A. Alavian S.M. Alene K.A. Ali K. Ali S.M. Alijanzadeh M. Alizadeh-Navaei R. Aljunid S.M. Alkerwi A. Alla F. Alsharif U. Altirkawi K. Alvis-Guzman N. Amare A.T. Ammar W. Anber N.H. Anderson J.A. Andrei C.L. Androudi S. Animut M.D. Anjomshoa M. Ansha M.G. Antó J.M. Antonio C.A.T. Anwari P. Appiah L.T. Appiah S.C.Y. Arabloo J. Aremu O. Ärnlöv J. Artaman A. Aryal K.K. Asayesh H. Ataro Z. Ausloos M. Avokpaho E.F.G.A. Awasthi A. Ayala Quintanilla B.P. Ayer R. Ayuk T.B. Azzopardi P.S. Babazadeh A. Badali H. Badawi A. Balakrishnan K. Bali A.G. Ball K. Ballew S.H. Banach M. Banoub J.A.M. Barac A. Barker-Collo S.L. Bärnighausen T.W. Barrero L.H. Basu S. Baune B.T. Bazargan-Hejazi S. Bedi N. Beghi E. Behzadifar M. Behzadifar M. Béjot Y. Bekele B.B. Bekru E.T. Belay E. Belay Y.A. Bell M.L. Bello A.K. Bennett D.A. Bensenor I.M. Bergeron G. Berhane A. Bernabe E. Bernstein R.S. Beuran M. Beyranvand T. Bhala N. Bhalla A. Bhattarai S. Bhutta Z.A. Biadgo B. Bijani A. Bikbov B. Bilano V. Bililign N. Bin Sayeed M.S. Bisanzio D. Biswas T. Bjørge T. Blacker B.F. Bleyer A. Borschmann R. Bou-Orm I.R. Boufous S. Bourne R. Brady O.J. Brauer M. Brazinova A. Breitborde N.J.K. Brenner H. Briko A.N. Britton G. Brugha T. Buchbinder R. Burnett R.T. Busse R. Butt Z.A. Cahill L.E. Cahuana-Hurtado L. Campos-Nonato I.R. Cárdenas R. Carreras G. Carrero J.J. Carvalho F. Castañeda-Orjuela C.A. Castillo Rivas J. Castro F. Catalá-López F. Causey K. Cercy K.M. Cerin E. Chaiah Y. Chang H-Y. Chang J-C. Chang K-L. Charlson F.J. Chattopadhyay A. Chattu V.K. Chee M.L. Cheng C-Y. Chew A. Chiang P.P-C. Chimed-Ochir O. Chin K.L. Chitheer A. Choi J-Y.J. Chowdhury R. Christensen H. Christopher D.J. Chung S-C. Cicuttini F.M. Cirillo M. Cohen A.J. Collado-Mateo D. Cooper C. Cooper O.R. Coresh J. Cornaby L. Cortesi P.A. Cortinovis M. Costa M. Cousin E. Criqui M.H. Cromwell E.A. Cundiff D.K. Daba A.K. Dachew B.A. Dadi A.F. Damasceno A.A.M. Dandona L. Dandona R. Darby S.C. Dargan P.I. Daryani A. Das Gupta R. Das Neves J. Dasa T.T. Dash A.P. Davitoiu D.V. Davletov K. De la Cruz-Góngora V. De La Hoz F.P. De Leo D. De Neve J-W. Degenhardt L. Deiparine S. Dellavalle R.P. Demoz G.T. Denova-Gutiérrez E. Deribe K. Dervenis N. Deshpande A. Des Jarlais D.C. Dessie G.A. Deveber G.A. Dey S. Dharmaratne S.D. Dhimal M. Dinberu M.T. Ding E.L. Diro H.D. Djalalinia S. Do H.P. Dokova K. Doku D.T. Doyle K.E. Driscoll T.R. Dubey M. Dubljanin E. Duken E.E. Duncan B.B. Duraes A.R. Ebert N. Ebrahimi H. Ebrahimpour S. Edvardsson D. Effiong A. Eggen A.E. El Bcheraoui C. El-Khatib Z. Elyazar I.R. Enayati A. Endries A.Y. Er B. Erskine H.E. Eskandarieh S. Esteghamati A. Estep K. Fakhim H. Faramarzi M. Fareed M. Farid T.A. Farinha C.S.E. Farioli A. Faro A. Farvid M.S. Farzaei M.H. Fatima B. Fay K.A. Fazaeli A.A. Feigin V.L. Feigl A.B. Fereshtehnejad S-M. Fernandes E. Fernandes J.C. Ferrara G. Ferrari A.J. Ferreira M.L. Filip I. Finger J.D. Fischer F. Foigt N.A. Foreman K.J. Fukumoto T. Fullman N. Fürst T. Furtado J.M. Futran N.D. Gall S. Gallus S. Gamkrelidze A. Ganji M. Garcia-Basteiro A.L. Gardner W.M. Gebre A.K. Gebremedhin A.T. Gebremichael T.G. Gelano T.F. Geleijnse J.M. Geramo Y.C.D. Gething P.W. Gezae K.E. Ghadimi R. Ghadiri K. Ghasemi Falavarjani K. Ghasemi-Kasman M. Ghimire M. Ghosh R. Ghoshal A.G. Giampaoli S. Gill P.S. Gill T.K. Gillum R.F. Ginawi I.A. Giussani G. Gnedovskaya E.V. Godwin W.W. Goli S. Gómez-Dantés H. Gona P.N. Gopalani S.V. Goulart A.C. Grada A. Grams M.E. Grosso G. Gugnani H.C. Guo Y. Gupta R. Gupta R. Gupta T. Gutiérrez R.A. Gutiérrez-Torres D.S. Haagsma J.A. Habtewold T.D. Hachinski V. Hafezi-Nejad N. Hagos T.B. Hailegiyorgis T.T. Hailu G.B. Haj-Mirzaian A. Haj-Mirzaian A. Hamadeh R.R. Hamidi S. Handal A.J. Hankey G.J. Hao Y. Harb H.L. Harikrishnan S. Haro J.M. Hassankhani H. Hassen H.Y. Havmoeller R. Hawley C.N. Hay S.I. Hedayatizadeh-Omran A. Heibati B. Heidari B. Heidari M. Hendrie D. Henok A. Heredia-Pi I. Herteliu C. Heydarpour F. Heydarpour S. Hibstu D.T. Higazi T.B. Hilawe E.H. Hoek H.W. Hoffman H.J. Hole M.K. Homaie Rad E. Hoogar P. Hosgood H.D. Hosseini S.M. Hosseinzadeh M. Hostiuc M. Hostiuc S. Hoy D.G. Hsairi M. Hsiao T. Hu G. Hu H. Huang J.J. Hussen M.A. Huynh C.K. Iburg K.M. Ikeda N. Ilesanmi O.S. Iqbal U. Irvani S.S.N. Irvine C.M.S. Islam S.M.S. Islami F. Jackson M.D. Jacobsen K.H. Jahangiry L. Jahanmehr N. Jain S.K. Jakovljevic M. James S.L. Jassal S.K. Jayatilleke A.U. Jeemon P. Jha R.P. Jha V. Ji J.S. Jonas J.B. Jonnagaddala J. Jorjoran Shushtari Z. Joshi A. Jozwiak J.J. Jürisson M. Kabir Z. Kahsay A. Kalani R. Kanchan T. Kant S. Kar C. Karami M. Karami Matin B. Karch A. Karema C. Karimi N. Karimi S.M. Kasaeian A. Kassa D.H. Kassa G.M. Kassa T.D. Kassebaum N.J. Katikireddi S.V. Kaul A. Kawakami N. Kazemi Z. Karyani A.K. Kefale A.T. Keiyoro P.N. Kemp G.R. Kengne A.P. Keren A. Kesavachandran C.N. Khader Y.S. Khafaei B. Khafaie M.A. Khajavi A. Khalid N. Khalil I.A. Khan G. Khan M.S. Khan M.A. Khang Y-H. Khater M.M. Khazaei M. Khazaie H. Khoja A.T. Khosravi A. Khosravi M.H. Kiadaliri A.A. Kiirithio D.N. Kim C-I. Kim D. Kim Y-E. Kim Y.J. Kimokoti R.W. Kinfu Y. Kisa A. Kissimova-Skarbek K. Kivimäki M. Knibbs L.D. Knudsen A.K.S. Kochhar S. Kokubo Y. Kolola T. Kopec J.A. Kosen S. Koul P.A. Koyanagi A. Kravchenko M.A. Krishan K. Krohn K.J. Kromhout H. Kuate Defo B. Kucuk Bicer B. Kumar G.A. Kumar M. Kuzin I. Kyu H.H. Lachat C. Lad D.P. Lad S.D. Lafranconi A. Lalloo R. Lallukka T. Lami F.H. Lang J.J. Lansingh V.C. Larson S.L. Latifi A. Lazarus J.V. Lee P.H. Leigh J. Leili M. Leshargie C.T. Leung J. Levi M. Lewycka S. Li S. Li Y. Liang J. Liang X. Liao Y. Liben M.L. Lim L-L. Linn S. Liu S. Lodha R. Logroscino G. Lopez A.D. Lorkowski S. Lotufo P.A. Lozano R. Lucas T.C.D. Lunevicius R. Ma S. Macarayan E.R.K. Machado Í.E. Madotto F. Mai H.T. Majdan M. Majdzadeh R. Majeed A. Malekzadeh R. Malta D.C. Mamun A.A. Manda A-L. Manguerra H. Mansournia M.A. Mantovani L.G. Maravilla J.C. Marcenes W. Marks A. Martin R.V. Martins S.C.O. Martins-Melo F.R. März W. Marzan M.B. Massenburg B.B. Mathur M.R. Mathur P. Matsushita K. Maulik P.K. Mazidi M. McAlinden C. McGrath J.J. McKee M. Mehrotra R. Mehta K.M. Mehta V. Meier T. Mekonnen F.A. Melaku Y.A. Melese A. Melku M. Memiah P.T.N. Memish Z.A. Mendoza W. Mengistu D.T. Mensah G.A. Mensink G.B.M. Mereta S.T. Meretoja A. Meretoja T.J. Mestrovic T. Mezgebe H.B. Miazgowski B. Miazgowski T. Millear A.I. Miller T.R. Miller-Petrie M.K. Mini G.K. Mirarefin M. Mirica A. Mirrakhimov E.M. Misganaw A.T. Mitiku H. Moazen B. Mohajer B. Mohammad K.A. Mohammadi M. Mohammadifard N. Mohammadnia-Afrouzi M. Mohammed S. Mohebi F. Mokdad A.H. Molokhia M. Momeniha F. Monasta L. Moodley Y. Moradi G. Moradi-Lakeh M. Moradinazar M. Moraga P. Morawska L. Morgado-Da-Costa J. Morrison S.D. Moschos M.M. Mouodi S. Mousavi S.M. Mozaffarian D. Mruts K.B. Muche A.A. Muchie K.F. Mueller U.O. Muhammed O.S. Mukhopadhyay S. Muller K. Musa K.I. Mustafa G. Nabhan A.F. Naghavi M. Naheed A. Nahvijou A. Naik G. Naik N. Najafi F. Nangia V. Nansseu J.R. Nascimento B.R. Neal B. Neamati N. Negoi I. Negoi R.I. Neupane S. Newton C.R.J. Ngunjiri J.W. Nguyen A.Q. Nguyen G. Nguyen H.T. Nguyen H.L.T. Nguyen H.T. Nguyen M. Nguyen N.B. Nichols E. Nie J. Ningrum D.N.A. Nirayo Y.L. Nishi N. Nixon M.R. Nojomi M. Nomura S. Norheim O.F. Noroozi M. Norrving B. Noubiap J.J. Nouri H.R. Nourollahpour Shiadeh M. Nowroozi M.R. Nsoesie E.O. Nyasulu P.S. Obermeyer C.M. Odell C.M. Ofori-Asenso R. Ogbo F.A. Oh I-H. Oladimeji O. Olagunju A.T. Olagunju T.O. Olivares P.R. Olsen H.E. Olusanya B.O. Olusanya J.O. Ong K.L. Ong S.K. Oren E. Orpana H.M. Ortiz A. Ota E. Otstavnov S.S. Øverland S. Owolabi M.O. P A M. Pacella R. Pakhare A.P. Pakpour A.H. Pana A. Panda-Jonas S. Park E-K. Parry C.D.H. Parsian H. Patel S. Pati S. Patil S.T. Patle A. Patton G.C. Paudel D. Paulson K.R. Paz Ballesteros W.C. Pearce N. Pereira A. Pereira D.M. Perico N. Pesudovs K. Petzold M. Pham H.Q. Phillips M.R. Pillay J.D. Piradov M.A. Pirsaheb M. Pischon T. Pishgar F. Plana-Ripoll O. Plass D. Polinder S. Polkinghorne K.R. Postma M.J. Poulton R. Pourshams A. Poustchi H. Prabhakaran D. Prakash S. Prasad N. Purcell C.A. Purwar M.B. Qorbani M. Radfar A. Rafay A. Rafiei A. Rahim F. Rahimi Z. Rahimi-Movaghar A. Rahimi-Movaghar V. Rahman M. Rahman M.H. Rahman M.A. Rai R.K. Rajati F. Rajsic S. Raju S.B. Ram U. Ranabhat C.L. Ranjan P. Rath G.K. Rawaf D.L. Rawaf S. Reddy K.S. Rehm C.D. Rehm J. Reiner R.C. Jr Reitsma M.B. Remuzzi G. Renzaho A.M.N. Resnikoff S. Reynales-Shigematsu L.M. Rezaei S. Ribeiro A.L.P. Rivera J.A. Roba K.T. Rodríguez-Ramírez S. Roever L. Román Y. Ronfani L. Roshandel G. Rostami A. Roth G.A. Rothenbacher D. Roy A. Rubagotti E. Rushton L. Sabanayagam C. Sachdev P.S. Saddik B. Sadeghi E. Saeedi Moghaddam S. Safari H. Safari Y. Safari-Faramani R. Safdarian M. Safi S. Safiri S. Sagar R. Sahebkar A. Sahraian M.A. Sajadi H.S. Salam N. Salamati P. Saleem Z. Salimi Y. Salimzadeh H. Salomon J.A. Salvi D.D. Salz I. Samy A.M. Sanabria J. Sanchez-Niño M.D. Sánchez-Pimienta T.G. Sanders T. Sang Y. Santomauro D.F. Santos I.S. Santos J.V. Santric Milicevic M.M. Sao Jose B.P. Sardana M. Sarker A.R. Sarmiento-Suárez R. Sarrafzadegan N. Sartorius B. Sarvi S. Sathian B. Satpathy M. Sawant A.R. Sawhney M. Saylan M. Sayyah M. Schaeffner E. Schmidt M.I. Schneider I.J.C. Schöttker B. Schutte A.E. Schwebel D.C. Schwendicke F. Scott J.G. Seedat S. Sekerija M. Sepanlou S.G. Serre M.L. Serván-Mori E. Seyedmousavi S. Shabaninejad H. Shaddick G. Shafieesabet A. Shahbazi M. Shaheen A.A. Shaikh M.A. Shamah Levy T. Shams-Beyranvand M. Shamsi M. Sharafi H. Sharafi K. Sharif M. Sharif-Alhoseini M. Sharifi H. Sharma J. Sharma M. Sharma R. She J. Sheikh A. Shi P. Shibuya K. Shiferaw M.S. Shigematsu M. Shin M-J. Shiri R. Shirkoohi R. Shiue I. Shokraneh F. Shoman H. Shrime M.G. Shupler M.S. Si S. Siabani S. Sibai A.M. Siddiqi T.J. Sigfusdottir I.D. Sigurvinsdottir R. Silva D.A.S. Silva J.P. Silveira D.G.A. Singh J.A. Singh N.P. Singh V. Sinha D.N. Skiadaresi E. Skirbekk V. Smith D.L. Smith M. Sobaih B.H. Sobhani S. Somayaji R. Soofi M. Sorensen R.J.D. Soriano J.B. Soyiri I.N. Spinelli A. Sposato L.A. Sreeramareddy C.T. Srinivasan V. Starodubov V.I. Steckling N. Stein D.J. Stein M.B. Stevanovic G. Stockfelt L. Stokes M.A. Sturua L. Subart M.L. Sudaryanto A. Sufiyan M.B. Sulo G. Sunguya B.F. Sur P.J. Sykes B.L. Szoeke C.E.I. Tabarés-Seisdedos R. Tabuchi T. Tadakamadla S.K. Takahashi K. Tandon N. Tassew S.G. Tavakkoli M. Taveira N. Tehrani-Banihashemi A. Tekalign T.G. Tekelemedhin S.W. Tekle M.G. Temesgen H. Temsah M-H. Temsah O. Terkawi A.S. Tessema B. Teweldemedhin M. Thankappan K.R. Theis A. Thirunavukkarasu S. Thomas H.J. Thomas M.L. Thomas N. Thurston G.D. Tilahun B. Tillmann T. To Q.G. Tobollik M. Tonelli M. Topor-Madry R. Torre A.E. Tortajada-Girbés M. Touvier M. Tovani-Palone M.R. Towbin J.A. Tran B.X. Tran K.B. Truelsen T.C. Truong N.T. Tsadik A.G. Tudor Car L. Tuzcu E.M. Tymeson H.D. Tyrovolas S. Ukwaja K.N. Ullah I. Updike R.L. Usman M.S. Uthman O.A. Vaduganathan M. Vaezi A. Valdez P.R. Van Donkelaar A. Varavikova E. Varughese S. Vasankari T.J. Venkateswaran V. Venketasubramanian N. Villafaina S. Violante F.S. Vladimirov S.K. Vlassov V. Vollset S.E. Vos T. Vosoughi K. Vu G.T. Vujcic I.S. Wagnew F.S. Waheed Y. Waller S.G. Walson J.L. Wang Y. Wang Y. Wang Y-P. Weiderpass E. Weintraub R.G. Weldegebreal F. Werdecker A. Werkneh A.A. West J.J. Westerman R. Whiteford H.A. Widecka J. Wijeratne T. Winkler A.S. Wiyeh A.B. Wiysonge C.S. Wolfe C.D.A. Wong T.Y. Wu S. Xavier D. Xu G. Yadgir S. Yadollahpour A. Yahyazadeh Jabbari S.H. Yamada T. Yan L.L. Yano Y. Yaseri M. Yasin Y.J. Yeshaneh A. Yimer E.M. Yip P. Yisma E. Yonemoto N. Yoon S-J. Yotebieng M. Younis M.Z. Yousefifard M. Yu C. Zaidi Z. Zaman S.B. Zamani M. Zavala-Arciniega L. Zhang A.L. Zhang H. Zhang K. Zhou M. Zimsen S.R.M. Zodpey S. Murray C.J.L. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018 392 10159 1923 1994 10.1016/S0140‑6736(18)32225‑6 30496105
    [Google Scholar]
16. Pengpid S. Vonglokham M. Kounnavong S. Sychareun V. Peltzer K. The prevalence, awareness, treatment, and control of hypertension among adults: The first cross-sectional national population-based survey in Laos. Vasc. Health Risk Manag. 2019 15 27 33 10.2147/VHRM.S199178 30881005
    [Google Scholar]
17. Nazarzadeh M. Bidel Z. Canoy D. Copland E. Bennett D.A. Dehghan A. Davey Smith G. Holman R.R. Woodward M. Gupta A. Adler A.I. Wamil M. Sattar N. Cushman W.C. McManus R.J. Teo K. Davis B.R. Chalmers J. Pepine C.J. Rahimi K. Agodoa L. Algra A. Asselbergs F.W. Beckett N. Berge E. Black H. Brouwers F.P.J. Brown M. Bulpitt C.J. Byington B. Cutler J. Devereaux R.B. Dwyer J. Estacio R. Fagard R. Fox K. Fukui T. Imai Y. Ishii M. Julius S. Kanno Y. Kjeldsen S.E. Kostis J. Kuramoto K. Lanke J. Lewis E. Lewis J. Lievre M. Lindholm L.H. Lueders S. MacMahon S. Mancia G. Matsuzaki M. Mehlum M.H. Nissen S. Ogawa H. Ogihara T. Ohkubo T. Palmer C. Patel A. Pfeffer M. Poulter N.R. Rakugi H. Reboldi G. Reid C. Remuzzi G. Ruggenenti P. Saruta T. Schrader J. Schrier R. Sever P. Sleight P. Staessen J.A. Suzuki H. Thijs L. Ueshima K. Umemoto S. van Gilst W.H. Verdecchia P. Wachtell K. Whelton P. Wing L. Yui Y. Yusuf S. Zanchetti A. Zhang Z.Y. Anderson C. Baigent C. Brenner B.M. Collins R. de Zeeuw D. Lubsen J. Malacco E. Neal B. Perkovic V. Pitt B. Rodgers A. Rothwell P. Salimi-Khorshidi G. Sundström J. Turnbull F. Viberti G. Wang J. Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: An individual participant-level data meta-analysis. Lancet Diabetes Endocrinol. 2022 10 9 645 654 10.1016/S2213‑8587(22)00172‑3 35878651
    [Google Scholar]
18. Chowdhury R. Khan H. Heydon E. Shroufi A. Fahimi S. Moore C. Stricker B. Mendis S. Hofman A. Mant J. Franco O.H. Adherence to cardiovascular therapy: A meta-analysis of prevalence and clinical consequences. Eur. Heart J. 2013 34 38 2940 2948 10.1093/eurheartj/eht295 23907142
    [Google Scholar]
19. Poulter N.R. Borghi C. Parati G. Pathak A. Toli D. Williams B. Schmieder R.E. Medication adherence in hypertension. J. Hypertens. 2020 38 4 579 587 10.1097/HJH.0000000000002294 31834123
    [Google Scholar]
20. Psaty B.M. Lumley T. Furberg C.D. Schellenbaum G. Pahor M. Alderman M.H. Weiss N.S. Health outcomes associated with various antihypertensive therapies used as first-line agents: A network meta-analysis. JAMA 2003 289 19 2534 2544 10.1001/jama.289.19.2534 12759325
    [Google Scholar]
21. Burnier M. Egan B.M. Adherence in Hypertension. Circ. Res. 2019 124 7 1124 1140 10.1161/CIRCRESAHA.118.313220 30920917
    [Google Scholar]
22. Carey R.M. Calhoun D.A. Bakris G.L. Brook R.D. Daugherty S.L. Dennison-Himmelfarb C.R. Egan B.M. Flack J.M. Gidding S.S. Judd E. Lackland D.T. Laffer C.L. Newton-Cheh C. Smith S.M. Taler S.J. Textor S.C. Turan T.N. White W.B. Resistant hypertension: Detection, evaluation, and management a scientific statement from the American Heart Association. Hypertension 2018 72 5 e53 e90 10.1161/HYP.0000000000000084 30354828
    [Google Scholar]
23. Chernova I. Krishnan N. Resistant hypertension updated guidelines. Curr. Cardiol. Rep. 2019 21 10 117 10.1007/s11886‑019‑1209‑6 31471727
    [Google Scholar]
24. Ettehad D. Emdin C.A. Kiran A. Anderson S.G. Callender T. Emberson J. Chalmers J. Rodgers A. Rahimi K. Blood pressure lowering for prevention of cardiovascular disease and death: A systematic review and meta-analysis. Lancet 2016 387 10022 957 967 10.1016/S0140‑6736(15)01225‑8 26724178
    [Google Scholar]
25. Dudenbostel T. Siddiqui M. Oparil S. Calhoun D.A. Refractory Hypertension. Hypertension 2016 67 6 1085 1092 10.1161/HYPERTENSIONAHA.116.06587 27091893
    [Google Scholar]
26. Tomaszewski M. White C. Patel P. Masca N. Damani R. Hepworth J. Samani N.J. Gupta P. Madira W. Stanley A. Williams B. High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis. Heart 2014 100 11 855 861 10.1136/heartjnl‑2013‑305063 24694797
    [Google Scholar]
27. Yano Y. Rakugi H. Bakris G.L. Lloyd-Jones D.M. Oparil S. Saruta T. Shimada K. Matsuoka H. Imai Y. Ogihara T. On-treatment blood pressure and cardiovascular outcomes in older adults with isolated systolic hypertension. Hypertension 2017 69 2 220 227 10.1161/HYPERTENSIONAHA.116.08600 28049699
    [Google Scholar]
28. Forzano I. Mone P. Varzideh F. Jankauskas S.S. Kansakar U. De Luca A. Santulli G. The selective aldosterone synthase inhibitor Baxdrostat significantly lowers blood pressure in patients with resistant hypertension. Front. Endocrinol. (Lausanne) 2022 13 1097968 10.3389/fendo.2022.1097968 36568122
    [Google Scholar]
29. Duggan S. Osilodrostat: First Approval. Drugs 2020 80 5 495 500 10.1007/s40265‑020‑01277‑0 32141023
    [Google Scholar]
30. MacKenzie S.M. Davies E. Alvarez-Madrazo S. Analysis of the aldosterone synthase (CYP11B2) and 11β-hydroxylase (CYP11B1) genes. Hypertension. Methods Mol. Biol. 2017 1527 139 150 10.1007/978‑1‑4939‑6625‑7_11 28116713
    [Google Scholar]
31. Bogman K. Schwab D. Delporte M.L. Palermo G. Amrein K. Mohr S. De Vera Mudry M.C. Brown M.J. Ferber P. Preclinical and early clinical profile of a highly selective and potent oral inhibitor of aldosterone synthase (CYP11B2). Hypertension 2017 69 1 189 196 10.1161/HYPERTENSIONAHA.116.07716 27872236
    [Google Scholar]
32. Freeman M.W. Halvorsen Y.D. Marshall W. Pater M. Isaacsohn J. Pearce C. Murphy B. Alp N. Srivastava A. Bhatt D.L. Brown M.J. Phase 2 trial of baxdrostat for treatment-resistant hypertension. N. Engl. J. Med. 2023 388 5 395 405 10.1056/NEJMoa2213169 36342143
    [Google Scholar]
33. Ojha U. Ruddaraju S. Sabapathy N. Ravindran V. Worapongsatitaya P. Haq J. Mohammed R. Patel V. Current and emerging classes of pharmacological agents for the management of hypertension. Am. J. Cardiovasc. Drugs 2022 22 3 271 285 10.1007/s40256‑021‑00510‑9 34878631
    [Google Scholar]
34. Shams E. Kamalumpundi V. Peterson J. Gismondi R.A. Oigman W. de Gusmão Correia M.L. Highlights of mechanisms and treatment of obesity-related hypertension. J. Hum. Hypertens. 2022 36 9 785 793 10.1038/s41371‑021‑00644‑y 35001082
    [Google Scholar]
35. Williamson W. Foster C. Reid H. Kelly P. Lewandowski A.J. Boardman H. Roberts N. McCartney D. Huckstep O. Newton J. Dawes H. Gerry S. Leeson P. Will Exercise advice be sufficient for treatment of young adults with prehypertension and hypertension? A systematic review and meta-analysis. Hypertension 2016 68 1 78 87 10.1161/HYPERTENSIONAHA.116.07431 27217408
    [Google Scholar]
36. Hinton T.C. Adams Z.H. Baker R.P. Hope K.A. Paton J.F.R. Hart E.C. Nightingale A.K. Investigation and treatment of high blood pressure in young people: Too much medicine or appropriate risk reduction? Hypertension 2020 75 1 16 22 10.1161/HYPERTENSIONAHA.119.13820 31735086
    [Google Scholar]
37. Williams B. Mancia G. Spiering W. Agabiti Rosei E. Azizi M. Burnier M. Clement D.L. Coca A. de Simone G. Dominiczak A. Kahan T. Mahfoud F. Redon J. Ruilope L. Zanchetti A. Kerins M. Kjeldsen S.E. Kreutz R. Laurent S. Lip G.Y.H. McManus R. Narkiewicz K. Ruschitzka F. Schmieder R.E. Shlyakhto E. Tsioufis C. Aboyans V. Desormais I. 2018 ESC/ESH Guidelines for the management of arterial hypertension. J. Hypertens. 2018 36 10 1953 2041 10.1097/HJH.0000000000001940 30234752
    [Google Scholar]
38. Pazoki R. Dehghan A. Evangelou E. Warren H. Gao H. Caulfield M. Elliott P. Tzoulaki I. Genetic predisposition to high blood pressure and lifestyle factors: Associations with midlife blood pressure levels and cardiovascular events. Circulation 2018 137 7 653 661 10.1161/CIRCULATIONAHA.117.030898 29254930
    [Google Scholar]
39. Raichlen D.A. Pontzer H. Harris J.A. Mabulla A.Z.P. Marlowe F.W. Josh Snodgrass J. Eick G. Colette Berbesque J. Sancilio A. Wood B.M. Physical activity patterns and biomarkers of cardiovascular disease risk in hunter‐gatherers. Am. J. Hum. Biol. 2017 29 2 e22919 10.1002/ajhb.22919 27723159
    [Google Scholar]
40. Kaplan H. Thompson R.C. Trumble B.C. Wann L.S. Allam A.H. Beheim B. Frohlich B. Sutherland M.L. Sutherland J.D. Stieglitz J. Rodriguez D.E. Michalik D.E. Rowan C.J. Lombardi G.P. Bedi R. Garcia A.R. Min J.K. Narula J. Finch C.E. Gurven M. Thomas G.S. Coronary atherosclerosis in indigenous South American Tsimane: A cross-sectional cohort study. Lancet 2017 389 10080 1730 1739 10.1016/S0140‑6736(17)30752‑3 28320601
    [Google Scholar]
41. Mueller N.T. Noya-Alarcon O. Contreras M. Appel L.J. Dominguez-Bello M.G. Association of age with blood pressure across the lifespan in isolated yanomami and yekwana villages. JAMA Cardiol. 2018 3 12 1247 1249 10.1001/jamacardio.2018.3676 30427998
    [Google Scholar]
42. Pescatello L.S. Buchner D.M. Jakicic J.M. Powell K. Kraus W. Bloodgood B. Campbell W.W. Dietz S. Dipietro L. George S.M. Macko R.F. McTiernan A. Pate R.R. Piercy K.L. Physical activity to prevent and treat hypertension: A systematic review. Med. Sci. Sports Exerc. 2019 51 6 1314 1323 10.1249/MSS.0000000000001943 31095088
    [Google Scholar]
43. Valenzuela P.L. Carrera-Bastos P. Gálvez B.G. Ruiz-Hurtado G. Ordovas J.M. Ruilope L.M. Lucia A. Lifestyle interventions for the prevention and treatment of hypertension. Nat. Rev. Cardiol. 2021 18 4 251 275 10.1038/s41569‑020‑00437‑9 33037326
    [Google Scholar]
44. Naci H. Salcher-Konrad M. Dias S. Blum M.R. Sahoo S.A. Nunan D. Ioannidis J.P.A. How does exercise treatment compare with antihypertensive medications? A network meta-analysis of 391 randomised controlled trials assessing exercise and medication effects on systolic blood pressure. Br. J. Sports Med. 2019 53 14 859 869 10.1136/bjsports‑2018‑099921 30563873
    [Google Scholar]
45. Smart N.A. Way D. Carlson D. Millar P. McGowan C. Swaine I. Baross A. Howden R. Ritti-Dias R. Wiles J. Cornelissen V. Gordon B. Taylor R. Bleile B. Effects of isometric resistance training on resting blood pressure. J. Hypertens. 2019 37 10 1927 1938 10.1097/HJH.0000000000002105 30889048
    [Google Scholar]
46. Jin Y.Z. Yan S. Yuan W.X. Effect of isometric handgrip training on resting blood pressure in adults: A meta-analysis of randomized controlled trials. J. Sports Med. Phys. Fitness 2017 57 1-2 154 160 10.23736/S0022‑4707.16.05887‑4 26558836
    [Google Scholar]
47. Conklin DJ Schick S Blaha MJ Carll A DeFilippis A Ganz P Cardiovascular injury induced by tobacco products: Assessment of risk factors and biomarkers of harm. A Tobacco Centers of Regulatory Science compilation. Am J Physiol Heart Circ Physiol. 2019 316 4 H801 H827 10.1152/ajpheart.00591.2018
    [Google Scholar]
48. Shim J.S. Heo J.E. Kim H.C. Factors associated with dietary adherence to the guidelines for prevention and treatment of hypertension among Korean adults with and without hypertension. Clin. Hypertens. 2020 26 1 5 10.1186/s40885‑020‑00138‑y 32190348
    [Google Scholar]
49. Wu Y. Johnson B.T. Acabchuk R.L. Chen S. Lewis H.K. Livingston J. Park C.L. Pescatello L.S. Yoga as antihypertensive lifestyle therapy: A systematic review and meta-analysis. Mayo Clin. Proc. 2019 94 3 432 446 10.1016/j.mayocp.2018.09.023 30792067
    [Google Scholar]
50. Ponte P. Castella M. Filella D. Feliu A. Matas L. Soler J. Ruiz M. Sole M.J. Ferrero M. Aguilera M. Roca-Cusachs A. Arroyo J.A. Benefits of mindfulness meditation in reducing blood pressure and stress in patients with arterial hypertension. J. Hypertens. 2018 36 Suppl. 1 e294 e295 10.1097/01.hjh.0000539863.81866.ac
    [Google Scholar]
51. Geiker N.R.W. Astrup A. Hjorth M.F. Sjödin A. Pijls L. Markus C.R. Does stress influence sleep patterns, food intake, weight gain, abdominal obesity and weight loss interventions and vice versa? Obes. Rev. 2018 19 1 81 97 10.1111/obr.12603 28849612
    [Google Scholar]
52. Tomiyama A.J. Stress and Obesity. Annu. Rev. Psychol. 2019 70 1 703 718 10.1146/annurev‑psych‑010418‑102936 29927688
    [Google Scholar]
53. Lowe C.J. Reichelt A.C. Hall P.A. The prefrontal cortex and obesity: A health neuroscience perspective. Trends Cogn. Sci. 2019 23 4 349 361 10.1016/j.tics.2019.01.005 30824229
    [Google Scholar]
54. Stults-Kolehmainen M.A. Sinha R. The effects of stress on physical activity and exercise. Sports Med. 2014 44 1 81 121 10.1007/s40279‑013‑0090‑5 24030837
    [Google Scholar]
55. Zhu B. Shi C. Park C.G. Zhao X. Reutrakul S. Effects of sleep restriction on metabolism-related parameters in healthy adults: A comprehensive review and meta-analysis of randomized controlled trials. Sleep Med. Rev. 2019 45 18 30 10.1016/j.smrv.2019.02.002 30870662
    [Google Scholar]
56. Terock J. Hannemann A. Janowitz D. Völzke H. Nauck M. Freyberger H.J. Wallaschofski H. Grabe H.J. Living alone and activation of the renin-angiotensin-aldosterone-system: Differential effects depending on alexithymic personality features. J. Psychosom. Res. 2017 96 42 48 10.1016/j.jpsychores.2017.03.007 28545792
    [Google Scholar]
57. Hermida R.C. Ayala D.E. Fontao M.J. Mojón A. Alonso I. Fernández J.R. Administration-time-dependent effects of spirapril on ambulatory blood pressure in uncomplicated essential hypertension. Chronobiol. Int. 2010 27 3 560 574 10.3109/07420528.2010.485411 20524801
    [Google Scholar]
58. Kaplan N.M. Chlorthalidone versus hydrochlorothiazide: A tale of tortoises and a hare. Hypertension 2011 58 6 994 995 10.1161/HYPERTENSIONAHA.111.183525 22025371
    [Google Scholar]
59. Kumar U. Wettersten N. Garimella P.S. Cardiorenal syndrome. Cardiol. Clin. 2019 37 3 251 265 10.1016/j.ccl.2019.04.001 31279419
    [Google Scholar]
60. Matchar D.B. McCrory D.C. Orlando L.A. Patel M.R. Patel U.D. Patwardhan M.B. Powers B. Samsa G.P. Gray R.N. Systematic review: Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension. Ann. Intern. Med. 2008 148 1 16 29 10.7326/0003‑4819‑148‑1‑200801010‑00189 17984484
    [Google Scholar]
61. Jensen C. Herold P. Brunner H.R. Aliskiren: The first renin inhibitor for clinical treatment. Nat. Rev. Drug Discov. 2008 7 5 399 410 10.1038/nrd2550 18340340
    [Google Scholar]
62. Julius S. Kjeldsen S.E. Weber M. Brunner H.R. Ekman S. Hansson L. Hua T. Laragh J. McInnes G.T. Mitchell L. Plat F. Schork A. Smith B. Zanchetti A. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: The VALUE randomised trial. Lancet 2004 363 9426 2022 2031 10.1016/S0140‑6736(04)16451‑9 15207952
    [Google Scholar]
63. Kavanagh R. Antihypertensive drugs. Side Effects of Drugs Annual 2020 42 215 226 10.1016/bs.seda.2020.07.009
    [Google Scholar]
64. Laurent S. Antihypertensive drugs. Pharmacol. Res. 2017 124 116 125 10.1016/j.phrs.2017.07.026 28780421
    [Google Scholar]
65. Musini V.M. Nazer M. Bassett K. Wright J.M. Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension. Cochrane Libr. 2014 2014 5 CD003824 10.1002/14651858.CD003824.pub2 24869750
    [Google Scholar]
66. Dahlöf B. Hansson L. Lindholm L.H. Scherstén B. Ekbom T. Wester P-O. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991 338 8778 1281 1285 10.1016/0140‑6736(91)92589‑T 1682683
    [Google Scholar]
67. Heran B.S. Galm B.P. Wright J.M. Blood pressure lowering efficacy of alpha blockers for primary hypertension. Cochrane Libr. 2012 8 8 CD004643 10.1002/14651858.CD004643.pub3 22895943
    [Google Scholar]
68. Wong G.W.K. Laugerotte A. Wright J.M. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension. Cochrane Libr. 2015 2015 8 CD007449 10.1002/14651858.CD007449.pub2 26306578
    [Google Scholar]
69. Macdougall A.I. Addis G.J. Mackay N. Dymock I.W. Turpie A.G.G. Ballingall D.L.K. Maclennan W.J. Whiting B. Macarthur J.G. Treatment of hypertension with clonidine. BMJ 1970 3 5720 440 442 10.1136/bmj.3.5720.440 5454324
    [Google Scholar]
70. Kandler M.R. Mah G.T. Tejani A.M. Stabler S.N. Salzwedel D.M. Hydralazine for essential hypertension. Cochrane Libr. 2011 9 11 CD004934 10.1002/14651858 22071816
    [Google Scholar]
71. Karmazyn M. Gan X.T. Chemical components of ginseng, their biotransformation products and their potential as treatment of hypertension. Mol. Cell. Biochem. 2021 476 1 333 347 10.1007/s11010‑020‑03910‑8 32940821
    [Google Scholar]
72. Uijl E. Mirabito Colafella K.M. Sun Y. Ren L. van Veghel R. Garrelds I.M. de Vries R. Poglitsch M. Zlatev I. Kim J.B. Hoorn E.J. Foster D. Danser A.H.J. Strong and sustained antihypertensive effect of small interfering rna targeting liver angiotensinogen. Hypertension 2019 73 6 1249 1257 10.1161/HYPERTENSIONAHA.119.12703 31030610
    [Google Scholar]
73. Humbert M. McLaughlin V. Gibbs J.S.R. Gomberg-Maitland M. Hoeper M.M. Preston I.R. Souza R. Waxman A. Escribano Subias P. Feldman J. Meyer G. Montani D. Olsson K.M. Manimaran S. Barnes J. Linde P.G. de Oliveira Pena J. Badesch D.B. Sotatercept for the treatment of pulmonary arterial hypertension. N. Engl. J. Med. 2021 384 13 1204 1215 10.1056/NEJMoa2024277 33789009
    [Google Scholar]
74. Gallo L.A. Wright E.M. Vallon V. Probing SGLT2 as a therapeutic target for diabetes: Basic physiology and consequences. Diab. Vasc. Dis. Res. 2015 12 2 78 89 10.1177/1479164114561992 25616707
    [Google Scholar]
75. Grant P.J. Cosentino F. The 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur. Heart J. 2019 40 39 3215 3217 10.1093/eurheartj/ehz687 31608951
    [Google Scholar]
76. McMurray J.J.V. Solomon S.D. Inzucchi S.E. Køber L. Kosiborod M.N. Martinez F.A. Ponikowski P. Sabatine M.S. Anand I.S. Bělohlávek J. Böhm M. Chiang C.E. Chopra V.K. de Boer R.A. Desai A.S. Diez M. Drozdz J. Dukát A. Ge J. Howlett J.G. Katova T. Kitakaze M. Ljungman C.E.A. Merkely B. Nicolau J.C. O’Meara E. Petrie M.C. Vinh P.N. Schou M. Tereshchenko S. Verma S. Held C. DeMets D.L. Docherty K.F. Jhund P.S. Bengtsson O. Sjöstrand M. Langkilde A.M. Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. N. Engl. J. Med. 2019 381 21 1995 2008 10.1056/NEJMoa1911303 31535829
    [Google Scholar]
77. Katsiki N. Mikhailidis D.P. Theodorakis M.J. Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i): Their Role in Cardiometabolic Risk Management. Curr. Pharm. Des. 2017 23 10 1522 1532 10.2174/1381612823666170113152742 28088910
    [Google Scholar]
78. Packer M. Anker S.D. Butler J. Filippatos G. Pocock S.J. Carson P. Januzzi J. Verma S. Tsutsui H. Brueckmann M. Jamal W. Kimura K. Schnee J. Zeller C. Cotton D. Bocchi E. Böhm M. Choi D.J. Chopra V. Chuquiure E. Giannetti N. Janssens S. Zhang J. Gonzalez Juanatey J.R. Kaul S. Brunner-La Rocca H.P. Merkely B. Nicholls S.J. Perrone S. Pina I. Ponikowski P. Sattar N. Senni M. Seronde M.F. Spinar J. Squire I. Taddei S. Wanner C. Zannad F. Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure. N. Engl. J. Med. 2020 383 15 1413 1424 10.1056/NEJMoa2022190 32865377
    [Google Scholar]
79. Mone P. Lombardi A. Kansakar U. Varzideh F. Jankauskas S.S. Pansini A. Marzocco S. De Gennaro S. Famiglietti M. Macina G. Frullone S. Santulli G. Empagliflozin improves the microRNA signature of endothelial dysfunction in patients with heart failure with preserved ejection fraction and diabetes. J. Pharmacol. Exp. Ther. 2023 384 1 116 122 10.1124/jpet.121.001251 36549862
    [Google Scholar]
80. Schumacher C.D. Steele R.E. Brunner H.R. Aldosterone synthase inhibition for the treatment of hypertension and the derived mechanistic requirements for a new therapeutic strategy. J. Hypertens. 2013 31 10 2085 2093 10.1097/HJH.0b013e328363570c 24107737
    [Google Scholar]
81. Williams B. MacDonald T.M. Morant S.V. Webb D.J. Sever P. McInnes G.T. Ford I. Cruickshank J.K. Caulfield M.J. Padmanabhan S. Mackenzie I.S. Salsbury J. Brown M.J. Balakrishnan K. Burton T. Cannon J. Collier D. Coughlan C. D’Souza R. Enobakhare E. Findlay E. Gardiner-Hill C. Gupta P. Helmy J. Helmy C. Hobbs L. Hobbs R. Hood S. Iles R. Kean S. Kwok S. Lacy P. MacIntyre I. Mackay J. Markandu N. Martin U. McCallum L. McCann G. McGinnis A. Melville V. Muir S. Myint K.S. Nazir S. Palmer J. Papworth R. Rutkowski K. Saxena M. Schumann A. Soran H. Stanley A. Thom S. Webb A. White C. Wilson R. Zak A. Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: The PATHWAY-2 mechanisms substudies. Lancet Diabetes Endocrinol. 2018 6 6 464 475 10.1016/S2213‑8587(18)30071‑8 29655877
    [Google Scholar]
82. Verdecchia P. Cavallini C. Angeli F. Advances in the treatment strategies in hypertension: Present and future. J. Cardiovasc. Dev. Dis. 2022 9 3 72 10.3390/jcdd9030072 35323620
    [Google Scholar]
83. Angeli F. Verdecchia P. Reboldi G. Aprocitentan, a dual endothelin receptor antagonist under development for the treatment of resistant hypertension. Cardiol. Ther. 2021 10 2 397 406 10.1007/s40119‑021‑00233‑7 34251649
    [Google Scholar]
84. Trensz F. Bortolamiol C. Kramberg M. Wanner D. Hadana H. Rey M. Strasser D.S. Delahaye S. Hess P. Vezzali E. Mentzel U. Ménard J. Clozel M. Iglarz M. Pharmacological characterization of aprocitentan, a dual endothelin receptor antagonist, alone and in combination with blockers of the renin angiotensin system, in two models of experimental hypertension. J. Pharmacol. Exp. Ther. 2019 368 3 462 473 10.1124/jpet.118.253864 30622171
    [Google Scholar]
85. Roubsanthisuk W. Kunanon S. Chattranukulchai P. Panchavinnin P. Wongpraparut N. Chaipromprasit J. Pienvichitr P. Ayudhya R.K.N. Sukonthasarn A. 2022 Renal denervation therapy for the treatment of hypertension: A statement from the Thai Hypertension Society. Hypertens. Res. 2023 46 4 898 912 10.1038/s41440‑022‑01133‑6 36759658
    [Google Scholar]
86. Oparil S. Schmieder R.E. New approaches in the treatment of hypertension. Circ. Res. 2015 116 6 1074 1095 10.1161/CIRCRESAHA.116.303603 25767291
    [Google Scholar]
87. Singh R.R. Denton K.M. Renal Denervation. Hypertension 2018 72 3 528 536 10.1161/HYPERTENSIONAHA.118.10265 30354761
    [Google Scholar]
88. van Kleef M.E.A.M. Bates M.C. Spiering W. Endovascular baroreflex amplification for resistant hypertension. Curr. Hypertens. Rep. 2018 20 5 46 10.1007/s11906‑018‑0840‑8 29744599
    [Google Scholar]
89. Iturriaga R. Carotid body ablation: A new target to address central autonomic dysfunction. Curr. Hypertens. Rep. 2018 20 6 53 10.1007/s11906‑018‑0849‑z 29789952
    [Google Scholar]
90. Azizi M. Schmieder R.E. Mahfoud F. Weber M.A. Daemen J. Davies J. Basile J. Kirtane A.J. Wang Y. Lobo M.D. Saxena M. Feyz L. Rader F. Lurz P. Sayer J. Sapoval M. Levy T. Sanghvi K. Abraham J. Sharp A.S.P. Fisher N.D.L. Bloch M.J. Reeve-Stoffer H. Coleman L. Mullin C. Mauri L. Wang Y. Jay D. Skeik N. Schwartz R. Rader F. Dohad S. Victor R. Sanghvi K. Costello J. Walsh C. Abraham J. Owan T. Abraham A. Fisher N.D.L. Mauri L. Sobieszczky P. Williams J. Bloch M.J. Roongsritong C. Todoran T. Basile J. Powers E. Hodskins E. Fong P. Laffer C. Gainer J. Robbins M. Reilly J.P. Cash M. Goldman J. Aggarwal S. Ledley G. Hsi D. Martin S. Portnay E. Calhoun D. McElderry T. Maddox W. Oparil S. Huang P-H. Jose P. Khuddus M. Zentko S. O’Meara J. Barb I. Garasic J. Drachman D. Zusman R. Rosenfield K. Devireddy C. Lea J. Wells B. Stouffer R. Hinderliter A. Pauley E. Potluri S. Biedermann S. Bangalore S. Williams S. Zidar D. Shishehbor M. Effron B. Costa M. Kirtane A.J. Radhakrishnan J. Lobo M.D. Saxena M. Mathur A. Jain A. Sayer J. Iyer S.G. Robinson N. Edroos S.A. Levy T. Patel A. Beckett D. Bent C. Davies J. Chapman N. Shun-Shin M. Howard J. Sharp A.S.P. Joseph A. D’Souza R. Gerber R. Faris M. Marshall A.J. Elorz C. Lurz P. Höllriegel R. Fengler K. Rommel K-P. Mahfoud F. Böhm M. Ewen S. Lucic J. Schmieder R.E. Ott C. Schmid A. Uder M. Rump L.C. Stegbauer J. Kröpil P. Azizi M. Sapoval M. Cornu E. Fouassier D. Gosse P. Cremer A. Trillaud H. Papadopoulos P. Pathak A. Honton B. Lantelme P. Berge C. Courand P-Y. Daemen J. Feyz L. Blankestijn P.J. Voskuil M. Rittersma Z. Kroon A.A. van Zwam W.H. Persu A. Renkin J. Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): A multicentre, international, single-blind, randomised, sham-controlled trial. Lancet 2018 391 10137 2335 2345 10.1016/S0140‑6736(18)31082‑1 29803590
    [Google Scholar]
91. Böhm M. Kario K. Kandzari D.E. Mahfoud F. Weber M.A. Schmieder R.E. Tsioufis K. Pocock S. Konstantinidis D. Choi J.W. East C. Lee D.P. Ma A. Ewen S. Cohen D.L. Wilensky R. Devireddy C.M. Lea J. Schmid A. Weil J. Agdirlioglu T. Reedus D. Jefferson B.K. Reyes D. D’Souza R. Sharp A.S.P. Sharif F. Fahy M. DeBruin V. Cohen S.A. Brar S. Townsend R.R. Akarca E. Allaqaband S. Andrikou E. Aoki J. Arnold A. Aronow H. Asami M. Bachinsky W. Barton J. Bass K. Batson B. Bell C. Bertolet B. Bewarder Y. Bihlmaier K. Binner C. Bloom J. Blossom B. Brar S. Brown A. Burke R. Burke M.N. Butler M. Calhoun W. Campbell J. Carroll S. Chapman N. Chasen C. Cheng S-C. Chia B. Choksi N. Cohen J. Connolly N. Contreras J. Cusack R. Dangas G. David S. Davies J. Dederer J. Denker M. Desch U. Didangelos M. Dienemann T. Dimitriadis K. Dorval J-F. Estess J. Fan S. Fengler K. Ferguson L. Fudim M. Fuster V. Garcia F. Garcia S. Garton A. Gessler C. Ghali M. Gummadi B. Gupta A. Gutierrez A. Hardesty P. Hartung P. Haught W.H. Haun Y. Hays S. Helmreich W. Hill D. Hopper I. Horiuchi Y. Hoshide S. Howard J. Ikeda W. Jan F. Jauhar R. Jay D. Johnson J. Johnston T. Jones S. Jung S. Kalos T. Kanitkar M. Kannenkeril D. Kasiakogias A. Kazziha S. Keene D. Khitha J. Kikushima H. Kobayashi T. Komiyama K. Komori T. Kotter J. Kouparanis A. Krasnow J. Kulenthiran S. Kumar S. L’Allier P. Laney P. Lauder L. Lavoie M.A. Lerche M. Linesky E. Little N. Lomboy C. Lucic J. Lurz P. Lynch S. Mansukhani P. McDuffie K. McGrath B. McLaurin B. Meade A. Meraj P. Millenaar D. Moore N. Mori F. Munch P. Murphy J. Murray J. Nanjundappa A. Ninomiya K. Oba Y. O’Connor T. Ogata Y. Ogoyama Y. Onsrud R. Ott C. Padaliya B. Pagidipati N. Patel M. Patel K. Petteinidou E. Porr W. Rao A. Razi R. Regan C. Remetz M. Rizik D. Robison M. Rommel K-P. Rosseel L. Rothstein M. Rough R. Saavedra J. Saba S. Schwartz R. Selcer S. Sen S. Sennott J. Shadman R. Shah S. Shemin D. Shimizu H. Shimpo M. Shishehbor M. Shun-Shin M. Sierra F. Singh J. Singh A. Sirajeldin Y. Skeik N. Soliman G. Statton S. Stehli J. Steigerwalt S. Striepe K. Stuck J. Suppan M. Svetkey L. Takker G. Tanabe K. Tanaka T. Tomii D. Torre S. Traverse J. Tyson C. Vasquez A. Velasquez E. Vemulapalli S. Waki H. Walton T. Wang Y. Weber T. Wells B. Wilkins R. Wright T. Yahagi K. Yeung A. Zadegan R. Zeller T. Ziada K. Ziakas A. Zidar D. Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): A multicentre, randomised, sham-controlled trial. Lancet 2020 395 10234 1444 1451 10.1016/S0140‑6736(20)30554‑7 32234534
    [Google Scholar]
92. Kandzari D.E. Böhm M. Mahfoud F. Townsend R.R. Weber M.A. Pocock S. Tsioufis K. Tousoulis D. Choi J.W. East C. Brar S. Cohen S.A. Fahy M. Pilcher G. Kario K. Aoki J. Batson B. Böhm M. Choi J.W. Cohen D.L. Dangas G. David S. Davies J. Devireddy C.M. Kandzari D. Kario K. Lee D.P. Lurz P.C. Papademetriou V. Patel M. Patel K. Schmieder R.E. Sharp A.S.P. Singh J. Tsioufis K. Walton A. Weber T. Weil J. Zeller T. Ziada K. Tanabe K. Wilkins R. Mahfoud F. East C. Wilensky R. Contreras J. Steigerwalt S. Chapman N. Lea J.P. Reedus D. Hoshide S. Ma A. Fengler K. Li P. Svetkey L. Rao A. Schmid A. Watkinson A.F. Brown A. Tousoulis D. Hopper I. Suppan M. Agdirlioglu T. Noory E. Chasen C. Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial. Lancet 2018 391 10137 2346 2355 10.1016/S0140‑6736(18)30951‑6 29803589
    [Google Scholar]
93. Parati G. Dolan E. McManus R.J. Omboni S. Home blood pressure telemonitoring in the 21st century. J. Clin. Hypertens. (Greenwich) 2018 20 7 1128 1132 10.1111/jch.13305 30003701
    [Google Scholar]
94. McManus R.J. Mant J. Franssen M. Nickless A. Schwartz C. Hodgkinson J. Bradburn P. Farmer A. Grant S. Greenfield S.M. Heneghan C. Jowett S. Martin U. Milner S. Monahan M. Mort S. Ogburn E. Perera-Salazar R. Shah S.A. Yu L.M. Tarassenko L. Hobbs F.D.R. Bradley B. Lovekin C. Judge D. Castello L. Dawson M. Brice R. Dunbabin B. Maslen S. Rutter H. Norris M. French L. Loynd M. Whitbread P. Saldana Ortaga L. Noel I. Madronal K. Timmins J. Bradburn P. Hughes L. Hinks B. Bailey S. Read S. Weston A. Spannuth S. Maiden S. Chermahini M. McDonald A. Rajan S. Allen S. Deboys B. Fell K. Johnson J. Jung H. Lister R. Osborne R. Secker A. Qasim I. William K. Harris A. Zhao S. Butcher E. Darbyshire P. Joshi S. Davies J. Talbot C. Hoverd E. Field L. Adcock T. Rooney J. Cooter N. Butler A. Allen N. Abdul-Wahab M. McNicholas K. Peniket L. Dodd K. Mugurza J. Baskerville R. Syed R. Bailey C. Adams J. Uglow P. Townsend N. Macleod A. Hawkins C. Behura S. Crawshaw J. Fox R. Doski W. Aylward M. A’Court C. Rapley D. Walsh J. Batra P. Seoane A. Mukherjee S. Dixon J. Arthur P. Sutcliffe K. Paschallides C. Woof R. Winfrey P. Clark M. Kamali R. Thomas P. Ebbs D. Mather L. Beattie A. Ladha K. Smondulak L. Jemahl S. Hickson P. Stevens L. Crockett T. Shukla D. Binnian I. Vinson P. DeKare-Silver N. Patel R. Singh I. Lumley L. Williams G. Webb M. Bambrough J. Shah N. Dosanjh H. Spannuth F. Paul C. Ganesegaram J. Pike L. Maheswaran V. Paruk F. Ford S. Verma V. Milne K. Lockhat F. Ferguson J. Quirk A-M. Wilson H. Copping D. Bajallan S. Tanvir S. Khan F. Alderson T. Ali A. Young R. Chauhan U. Crockett L. McGovern L. Cubitt C. Weatherill S. Tabassum A. Saunders P. Chauhan N. Johnson S. Walsh J. Marok I. Sharma R. Lumb W. Tweedale J. Smith I. Miller L. Ahmed T. Sanderson M. Jones C. Stokell P. Edwards M.J. Askey A. Spencer J. Morgan K. Knox K. Baker R. Fisher C. Halstead R. Modha N. Buckley D. Stokell C. McCabe J.G. Taylor J. Nutbeam H. Smith R. MacGregor C. Davies S. Lindsey M. Cartwright S. Whittle J. Colclough J. Crumbie A. Thomas N. Premchand V. Hamid R. Ali Z. Ward J. Pinney P. Thurston S. Banerjee T. Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): An unmasked randomised controlled trial. Lancet 2018 391 10124 949 959 10.1016/S0140‑6736(18)30309‑X 29499873
    [Google Scholar]
95. Zhang W. Zhang S. Deng Y. Wu S. Ren J. Sun G. Yang J. Jiang Y. Xu X. Wang T.D. Chen Y. Li Y. Yao L. Li D. Wang L. Shen X. Yin X. Liu W. Zhou X. Zhu B. Guo Z. Liu H. Chen X. Feng Y. Tian G. Gao X. Kario K. Cai J. Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension. N. Engl. J. Med. 2021 385 14 1268 1279 10.1056/NEJMoa2111437 34491661
    [Google Scholar]
96. Widmer R.J. Collins N.M. Collins C.S. West C.P. Lerman L.O. Lerman A. Digital health interventions for the prevention of cardiovascular disease: A systematic review and meta-analysis. Mayo Clin. Proc. 2015 90 4 469 480 10.1016/j.mayocp.2014.12.026 25841251
    [Google Scholar]
97. Burke L.E. Ma J. Azar K.M.J. Bennett G.G. Peterson E.D. Zheng Y. Riley W. Stephens J. Shah S.H. Suffoletto B. Turan T.N. Spring B. Steinberger J. Quinn C.C. Current Science on Consumer Use of Mobile Health for Cardiovascular Disease Prevention. Circulation 2015 132 12 1157 1213 10.1161/CIR.0000000000000232 26271892
    [Google Scholar]
98. Treskes R.W. van Winden L.A.M. van Keulen N. van der Velde E.T. Beeres S.L.M.A. Atsma D.E. Schalij M.J. Effect of smartphone-enabled health monitoring devices vs regular follow-up on blood pressure control among patients after myocardial infarction. JAMA Netw. Open 2020 3 4 e202165 10.1001/jamanetworkopen.2020.2165 32297946
    [Google Scholar]
99. Tison G.H. Singh A.C. Ohashi D.A. Hsieh J.T. Ballinger B.M. Olgin J.E. Marcus G.M. Pletcher M.J. Cardiovascular risk stratification using off-the-shelf wearables and a multi-task deep learning algorithm. Circulation 2017 136 Suppl. 1 A21042 10.1161/circ.136.suppl_1.21042
    [Google Scholar]
100. Duan Y. Xie Z. Dong F. Wu Z. Lin Z. Sun N. Xu J. Effectiveness of home blood pressure telemonitoring: A systematic review and meta-analysis of randomised controlled studies. J. Hum. Hypertens. 2017 31 7 427 437 10.1038/jhh.2016.99 28332506
     [Google Scholar]
101. Pellegrini D. Torlasco C. Ochoa J.E. Parati G. Contribution of telemedicine and information technology to hypertension control. Hypertens. Res. 2020 43 7 621 628 10.1038/s41440‑020‑0422‑4 32203451
     [Google Scholar]
102. Patel N. Thompson N. Mehra R. Waters T. Foldvary-Schaefer N. Kominksy A. Aylor J. Walia H. 0572 Impact of Upper Airway Stimulation Therapy on Clinical Blood pressure Parameters from the ADHERE Registry. Sleep 2019 42 Suppl. 1 A228 10.1093/sleep/zsz067.570
     [Google Scholar]
103. Johnson R.J. Choi H.K. Yeo A.E. Lipsky P.E. Pegloticase treatment significantly decreases blood pressure in patients with chronic gout. Hypertension 2019 74 1 95 101 10.1161/HYPERTENSIONAHA.119.12727 31079535
     [Google Scholar]
104. Bove M. Cicero A.F.G. Borghi C. The Effect of Xanthine Oxidase Inhibitors on Blood Pressure and Renal Function. Curr. Hypertens. Rep. 2017 19 12 95 10.1007/s11906‑017‑0793‑3 29071435
     [Google Scholar]
105. DiPette D.J. Goughnour K. Zuniga E. Skeete J. Ridley E. Angell S. Brettler J. Campbell N.R.C. Coca A. Connell K. Doon R. Jaffe M. Lopez-Jaramillo P. Moran A. Orias M. Pineiro D.J. Rosende A. González Y.V. Ordunez P. Standardized treatment to improve hypertension control in primary health care: The HEARTS in the Americas Initiative. J. Clin. Hypertens. (Greenwich) 2020 22 12 2285 2295 10.1111/jch.14072 33045133
     [Google Scholar]
106. Ghaffari S. Roshanravan N. The role of nutraceuticals in prevention and treatment of hypertension: An updated review of the literature. Food Res. Int. 2020 128 108749 10.1016/j.foodres.2019.108749 31955788
     [Google Scholar]
107. Yung L.M. Yang P. Joshi S. Augur Z.M. Kim S.S.J. Bocobo G.A. Dinter T. Troncone L. Chen P.S. McNeil M.E. Southwood M. Poli de Frias S. Knopf J. Rosas I.O. Sako D. Pearsall R.S. Quisel J.D. Li G. Kumar R. Yu P.B. ACTRIIA-Fc rebalances activin/GDF versus BMP signaling in pulmonary hypertension. Sci. Transl. Med. 2020 12 543 eaaz5660 10.1126/scitranslmed.aaz5660 32404506
     [Google Scholar]
108. Azegami T. Itoh H. Vaccine Development against the Renin-Angiotensin System for the Treatment of Hypertension. Int. J. Hypertens. 2019 2019 1 8 10.1155/2019/9218531 31485348
     [Google Scholar]
109. Azegami T. Yuki Y. Nakahashi R. Itoh H. Kiyono H. Nanogel-based nasal vaccines for infectious and lifestyle-related diseases. Mol. Immunol. 2018 98 19 24 10.1016/j.molimm.2017.10.022 29096936
     [Google Scholar]
110. Yang T. Mei X. Tackie-Yarboi E. Akere M.T. Kyoung J. Mell B. Yeo J.Y. Cheng X. Zubcevic J. Richards E.M. Pepine C.J. Raizada M.K. Schiefer I.T. Joe B. Identification of a Gut Commensal That Compromises the Blood Pressure-Lowering Effect of Ester Angiotensin-Converting Enzyme Inhibitors. Hypertension 2022 79 8 1591 1601 10.1161/HYPERTENSIONAHA.121.18711 35538603
     [Google Scholar]
111. Wilson I.D. Nicholson J.K. Gut microbiome interactions with drug metabolism, efficacy, and toxicity. Transl. Res. 2017 179 204 222 10.1016/j.trsl.2016.08.002 27591027
     [Google Scholar]
112. Loaiza-Betancur A.F. Chulvi-Medrano I. Is low-intensity isometric handgrip exercise an efficient alternative in lifestyle blood pressure management? A systematic review. Sports Health 2020 12 5 470 477 10.1177/1941738120943882 32776866
     [Google Scholar]
113. (a López-Valenciano A. Ruiz-Pérez I. Ayala F. Sánchez-Meca J. Vera-Garcia F.J. Updated systematic review and meta-analysis on the role of isometric resistance training for resting blood pressure management in adults J. Hypertens. 2019 37 7 1320 1333 10.1097/HJH.0000000000002022 30624369
     [Google Scholar]
114. (b Smart N.A. Way D. Carlson D. Effects of isometric resistance training on resting blood pressure J. Hypertens. 2019 37 10 1927 11938 10.1097/hjh.0000000000002105 30889048
     [Google Scholar]